Creating transplant tolerance by taming adverse intragraft innate immunity

Certain forms of inflammation of an allograft are highly detrimental to the induction and maintenance of transplant tolerance as they foster stable commitment to graft-destructive, not graft-protective, forms of T-cell immunity. Hence, a reduction in adverse tissue inflammation may prove crucial in facilitating the induction and maintenance of a long-lasting state of transplant tolerance.

• Publication year

  2010

• Venue

  F1000 Biology Reports

• Publication date

  2010-11-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3410/B2-83PMID 21283601PMCID 3026643
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Steroid Pretreatment of Organ Donors to Prevent Postischemic Renal Allograft Failure

  2010cited by this paper
• Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting.

  2010cited by this paper
• Inflammation and the balance of Treg and Th17 cells in transplant rejection and tolerance

  2010cited by this paper
• In vivo expansion of T reg cells with IL-2–mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression

  2009cited by this paper
• Epigenetic mechanisms of regulation of Foxp3 expression.

  2009influential reference
• TLR Signals Promote IL-6/IL-17-Dependent Transplant Rejection1

  2009cited by this paper
• Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation

  2009cited by this paper
• Regulatory T‐Cell Counter‐Regulation by Innate Immunity Is a Barrier to Transplantation Tolerance

  2009cited by this paper
• A brief focus on memory cells in transplantation.

  2009cited by this paper
• Levels of Foxp3 in Regulatory T Cells Reflect Their Functional Status in Transplantation1

  2009cited by this paper
• Recently discovered T cell subsets cannot keep their commitments.

  2009cited by this paper
• Heterogeneity of natural Foxp3+ T cells: A committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity

  2009cited by this paper
• Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?

  2009cited by this paper
• Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo

  2009cited by this paper
• Cytokine related therapies for autoimmune disease.

  2008cited by this paper
• Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes

  2008cited by this paper
• DNA methylation controls Foxp3 gene expression

  2008cited by this paper
• Curative and β cell regenerative effects of α1-antitrypsin treatment in autoimmune diabetic NOD mice

  2008cited by this paper
• The protective role of steroids in ischemia-reperfusion injury of the liver.

  2008cited by this paper
• Glucocorticoids reduce pro‐inflammatory cytokines and tissue factor in vitro and improve function of transplanted human islets in vivo

  2008cited by this paper
• Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.

  2008cited by this paper
• TIM-4 Expressed on APCs Induces T Cell Expansion and Survival1

  2008cited by this paper
• α1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice

  2008cited by this paper
• Molecular antagonism and plasticity of regulatory and inflammatory T cell programs.

  2008cited by this paper
• Modification of adverse inflammation is required to cure new-onset type 1 diabetic hosts

  2007cited by this paper
• Nonredundant roles for Stat5a/b in directly regulating Foxp3.

  2007cited by this paper
• Contrasting Effects of Cyclosporine and Rapamycin in De Novo Generation of Alloantigen‐Specific Regulatory T Cells

  2007cited by this paper
• 2006 Homer W. Smith Lecture: taming T cells.

  2007cited by this paper
• IL-2 Receptor β-Dependent STAT5 Activation Is Required for the Development of Foxp3+ Regulatory T Cells1

  2007influential reference
• Deacetylase inhibition promotes the generation and function of regulatory T cells

  2007cited by this paper
• Graft Produced Interleukin-6 Functions as a Danger Signal and Promotes Rejection After Transplantation

  2007cited by this paper
• Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3

  2007cited by this paper
• Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation.

  2007cited by this paper
• Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

  2006cited by this paper
• TIM-4 is the ligand for TIM-1, and the TIM-1–TIM-4 interaction regulates T cell proliferation

  2005cited by this paper
• Glucocorticoids decrease the bioavailability of TGF-beta which leads to a reduced TGF-beta signaling in hepatic stellate cells.

  2004cited by this paper
• Glucocorticoids decrease the bioavailability of TGF-β which leads to a reduced TGF-β signaling in hepatic stellate cells

  2004cited by this paper
• Toll Pathway-Dependent Blockade of CD4+CD25+ T Cell-Mediated Suppression by Dendritic Cells

  2003cited by this paper
• Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice.

  2002cited by this paper
• A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts.

  2001cited by this paper
• Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance

  1999cited by this paper

• BET Protein Inhibition Prolongs Cardiac Transplant Survival via Enhanced Myocardial Autophagy

  2020cites this paper
• A novel rat full‐thickness hemi‐abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival

  2014cites this paper
• Clinical operational tolerance in liver transplantation: state-of-the-art perspective and future prospects.

  2013cites this paper
• The Role of Mesenchymal Stem Cells in Organ Transplantation Immunomodulatory and Anti-inflammatory Properties of Mesenchymal Stem Cells for Application in Organ Transplantation

  2013cites this paper
• Towards cytoprotection in the peritransplant period.

  2011cites this paper